The discovery of “dark matter” may alter cancer treatment

Researchers have learned more about the enigmatic function of epigenetics,
the study of how genes change in regulating the growth of tumors.

It is sometimes referred to as “dark matter,” Studies from The Institute of
Cancer Research reveal that it may change how cancer is identified and
treated.

Additionally, it might result in novel disease-related diagnostics that
could be used to better target therapies.

However, this is still a long way off, and research is just starting.

The DNA code’s structural variations passed down across generations come to
mind when most people think of genetics.

The mechanism by which these gene changes promote the spread of
malignancies has received considerable attention.